全膝关节置换术后的院内阿片类药物暴露与阿片类药物处方
这项回顾性研究纳入2020年5月1日至2023年11月30日由同一位骨科医生完成单侧初次全膝关节置换术的阿片类药物初治患者,分析术后3个月内是否填写阿片类药物处方与院内阿片类药物暴露的关系。术后3个月29.8%的患者填写了阿片类药物处方,中位吗啡毫克当量为210。多变量分析显示,较低的术前疼痛评分是唯一与全膝关节置换术后填写阿片类药物处方可能性降低相关的变量(校正比值比=0.675,P=0.002)。
要点
- 术后3个月内29.8%的阿片类药物初治患者填写了阿片类药物处方,中位吗啡毫克当量为210。
- OP-T组术后麻醉恢复室接受静脉阿片类药物的比例高于NOP-T组(45.2% vs 27.3%,P=0.037)。
- 较低的术前疼痛评分是唯一与术后填写阿片类药物处方可能性降低相关的变量(校正比值比=0.675,P=0.002)。
核心结论
- 本研究强调现代无阿片类药物多模式镇痛方案在优化全膝关节置换术后疼痛管理中的重要性。
- 通过尽量减少全膝关节置换术前及住院期间的阿片类药物暴露,患者可实现良好的疼痛控制并避免阿片类药物暴露的危害。
研究设计与样本
- 回顾性研究,纳入2020年5月1日至2023年11月30日由一位骨科医生完成的单侧初次全膝关节置换术的阿片类药物初治患者(术前3个月内未填写阿片类药物处方)。
- 所有患者均采用相同的多模式疼痛方案治疗。
- 分析术后3个月内填写阿片类药物处方(OP-T组)与未填写阿片类药物处方(NOP-T组)患者与院内阿片类药物暴露的关系。
主要发现
- 术后3个月内29.8%的患者填写了阿片类药物处方(OP-T组),中位吗啡毫克当量为210。
- OP-T组与NOP-T组人口学特征相似,唯一显著差异为不同保险类型的阿片类药物处方率,其中医疗补助参保者术后阿片类药物处方比例最高。
- NOP-T组术前报告的疼痛显著更轻且功能更好。
- OP-T组术后麻醉恢复室接受静脉阿片类药物的患者比例更高(45.2% vs 27.3%,P=0.037)。
- 多变量分析显示,较低的术前疼痛评分是唯一与全膝关节置换术后填写阿片类药物处方可能性降低相关的变量(校正比值比=0.675,P=0.002)。
关键数值与推荐
- 术后3个月内填写阿片类药物处方的患者比例为29.8%,中位吗啡毫克当量为210。
- OP-T组术后麻醉恢复室接受静脉阿片类药物的比例为45.2%,NOP-T组为27.3%(P=0.037)。
- 较低术前疼痛评分与术后填写阿片类药物处方可能性降低相关,校正比值比=0.675,P=0.002。
临床怎么用
- 原文结论指出,现代无阿片类药物多模式镇痛方案对优化全膝关节置换术后疼痛管理具有重要性。
- 原文结论指出,尽量减少全膝关节置换术前及住院期间的阿片类药物暴露,有助于患者实现良好疼痛控制并避免阿片类药物暴露的危害。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Opioids are frequently used intraoperatively and during postanesthesia care unit care in total knee arthroplasty (TKA) cases and are commonly prescribed after surgery despite known adverse effects. This study examined whether in-hospital opioid exposure is related to postoperative opioid prescribing in opioid-naïve TKA patients. METHODS: This retrospective study included opioid-naïve patients (no opioid prescriptions filled during the three months before TKA) who had unilateral primary TKA between May 1, 2020, and November 30, 2023, performed by an orthopaedic surgeon. All patients were treated using the same multimodal pain protocol. Opioid prescriptions filled by patients during the three months following TKA (no opioids prescribed [NOP-T] versus opioids prescribed [OP-T]) were analyzed as a function of inhospital opioid exposure. RESULTS: In the three months after surgery, 29.8% of patients filled an opioid prescription (OP-T group) with a median morphine milligram equivalent (MME) of 210. The OP-T and NOP-T groups had similar demographic characteristics except for a significant difference in opioid prescribing by insurance type, with Medicaid enrollees having the highest percentage of postoperative opioid prescriptions. In addition, the NOP-T group reported significantly less pain and better function preoperatively. A higher percentage of patients in the OP-T group received intravenous opioids in the postanesthesia care unit (45.2 versus 27.3%, P = 0.037). Multivariable analyses showed that a lower preoperative pain score was the only variable associated with a reduced likelihood of filling an opioid prescription after TKA (adjusted odds ratio = 0.675, P = 0.002). CONCLUSIONS: This study highlights the importance of a modern opioid-free multimodal analgesia regimen in optimizing pain management after TKA. By minimizing opioid exposure before TKA and during in-hospital treatment, TKA patients can achieve good pain control while avoiding the hazards of opioid exposure.
引用
- Daigle C, Branstetter R, Van Deventer L, et al. In-Hospital Exposure and Opioids Prescribed after Total Knee Arthroplasty. J Arthroplasty. 2025. PMID: 40946937. doi:10.1016/j.arth.2025.09.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。